143 related articles for article (PubMed ID: 14717920)
1. 5-Aminoisoquinolinone reduces renal injury and dysfunction caused by experimental ischemia/reperfusion.
Chatterjee PK; Chatterjee BE; Pedersen H; Sivarajah A; McDonald MC; Mota-Filipe H; Brown PA; Stewart KN; Cuzzocrea S; Threadgill MD; Thiemermann C
Kidney Int; 2004 Feb; 65(2):499-509. PubMed ID: 14717920
[TBL] [Abstract][Full Text] [Related]
2. Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat.
Chatterjee PK; Cuzzocrea S; Brown PA; Zacharowski K; Stewart KN; Mota-Filipe H; Thiemermann C
Kidney Int; 2000 Aug; 58(2):658-73. PubMed ID: 10916089
[TBL] [Abstract][Full Text] [Related]
3. Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase on the organ injury and dysfunction caused by haemorrhagic shock.
McDonald MC; Mota-Filipe H; Wright JA; Abdelrahman M; Threadgill MD; Thompson AS; Thiemermann C
Br J Pharmacol; 2000 Jun; 130(4):843-50. PubMed ID: 10864891
[TBL] [Abstract][Full Text] [Related]
4. The novel PARP inhibitor 5-aminoisoquinolinone reduces the liver injury caused by ischemia and reperfusion in the rat.
Mota-Filipe H; Sepodes B; McDonald MC; Cuzzocrea S; Pinto R; Thiemermann C
Med Sci Monit; 2002 Nov; 8(11):BR444-53. PubMed ID: 12444369
[TBL] [Abstract][Full Text] [Related]
5. EUK-134 reduces renal dysfunction and injury caused by oxidative and nitrosative stress of the kidney.
Chatterjee PK; Patel NS; Kvale EO; Brown PA; Stewart KN; Mota-Filipe H; Sharpe MA; Di Paola R; Cuzzocrea S; Thiemermann C
Am J Nephrol; 2004; 24(2):165-77. PubMed ID: 14752229
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of poly (ADP-ribose) synthetase protect rat proximal tubular cells against oxidant stress.
Chatterjee PK; Cuzzocrea S; Thiemermann C
Kidney Int; 1999 Sep; 56(3):973-84. PubMed ID: 10469365
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of 5-aminoisoquinolinone, a novel, potent, water-soluble, inhibitor of poly (ADP-ribose) polymerase, in a rat model of splanchnic artery occlusion and reperfusion.
Di Paola R; Genovese T; Caputi AP; Threadgill M; Thiemermann C; Cuzzocrea S
Eur J Pharmacol; 2004 May; 492(2-3):203-10. PubMed ID: 15178366
[TBL] [Abstract][Full Text] [Related]
8. The tyrosine kinase inhibitor tyrphostin AG126 reduces renal ischemia/reperfusion injury in the rat.
Chatterjee PK; Patel NS; Kvale EO; Brown PA; Stewart KN; Britti D; Cuzzocrea S; Mota-Filipe H; Thiemermann C
Kidney Int; 2003 Nov; 64(5):1605-19. PubMed ID: 14531792
[TBL] [Abstract][Full Text] [Related]
9. 5-Aminoisoquinolinone, a novel inhibitor of poly(adenosine disphosphate-ribose) polymerase, reduces microvascular liver injury but not mortality rate after hepatic ischemia-reperfusion.
Khandoga A; Biberthaler P; Enders G; Krombach F
Crit Care Med; 2004 Feb; 32(2):472-7. PubMed ID: 14758166
[TBL] [Abstract][Full Text] [Related]
10. GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury.
Chatterjee PK; Patel NS; Sivarajah A; Kvale EO; Dugo L; Cuzzocrea S; Brown PA; Stewart KN; Mota-Filipe H; Britti D; Yaqoob MM; Thiemermann C
Kidney Int; 2003 Mar; 63(3):853-65. PubMed ID: 12631066
[TBL] [Abstract][Full Text] [Related]
11. TEMPONE reduces renal dysfunction and injury mediated by oxidative stress of the rat kidney.
Patel NS; Chatterjee PK; Chatterjee BE; Cuzzocrea S; Serraino I; Brown PA; Stewart KN; Mota-Filipe H; Thiemermann C
Free Radic Biol Med; 2002 Dec; 33(11):1575-89. PubMed ID: 12446215
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury.
Chatterjee PK; Patel NS; Kvale EO; Cuzzocrea S; Brown PA; Stewart KN; Mota-Filipe H; Thiemermann C
Kidney Int; 2002 Mar; 61(3):862-71. PubMed ID: 11849439
[TBL] [Abstract][Full Text] [Related]
13. Influence of 5-aminoisoquinolin-1-one (5-AIQ) on neutrophil chemiluminescence in rats with transient and prolonged focal cerebral ischemia and after reperfusion.
Hendryk S; Czuba ZP; Jedrzejowska-Szypulka H; Szliszka E; Phillips VA; Threadgill MD; Krol W
J Physiol Pharmacol; 2008 Dec; 59(4):811-22. PubMed ID: 19212013
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of caspase inhibitors on the renal dysfunction and injury caused by ischemia-reperfusion of the rat kidney.
Chatterjee PK; Todorovic Z; Sivarajah A; Mota-Filipe H; Brown PA; Stewart KN; Cuzzocrea S; Thiemermann C
Eur J Pharmacol; 2004 Oct; 503(1-3):173-83. PubMed ID: 15496312
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of poly (ADP-ribose) synthetase reduce renal ischemia-reperfusion injury in the anesthetized rat in vivo.
Chatterjee PK; Zacharowski K; Cuzzocrea S; Otto M; Thiemermann C
FASEB J; 2000 Apr; 14(5):641-51. PubMed ID: 10744621
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated bcl-2 gene transfer inhibits renal ischemia/reperfusion induced tubular oxidative stress and apoptosis.
Chien CT; Chang TC; Tsai CY; Shyue SK; Lai MK
Am J Transplant; 2005 Jun; 5(6):1194-203. PubMed ID: 15888023
[TBL] [Abstract][Full Text] [Related]
17. Lipoteichoic acid from Staphylococcus aureus reduces renal ischemia/reperfusion injury.
Chatterjee PK; Zacharowski K; Cuzzocrea S; Brown PA; Stewart KN; Mota-Filipe H; Thiemermann C
Kidney Int; 2002 Oct; 62(4):1249-63. PubMed ID: 12234295
[TBL] [Abstract][Full Text] [Related]
18. A novel and orally active poly(ADP-ribose) polymerase inhibitor, KR-33889 [2-[methoxycarbonyl(4-methoxyphenyl) methylsulfanyl]-1H-benzimidazole-4-carboxylic acid amide], attenuates injury in in vitro model of cell death and in vivo model of cardiac ischemia.
Oh KS; Lee S; Yi KY; Seo HW; Koo HN; Lee BH
J Pharmacol Exp Ther; 2009 Jan; 328(1):10-8. PubMed ID: 18836068
[TBL] [Abstract][Full Text] [Related]
19. Bcl-xL augmentation potentially reduces ischemia/reperfusion induced proximal and distal tubular apoptosis and autophagy.
Chien CT; Shyue SK; Lai MK
Transplantation; 2007 Nov; 84(9):1183-90. PubMed ID: 17998875
[TBL] [Abstract][Full Text] [Related]
20. Oxidant-induced cardiomyocyte injury: identification of the cytoprotective effect of a dopamine 1 receptor agonist using a cell-based high-throughput assay.
Gerö D; Módis K; Nagy N; Szoleczky P; Tóth ZD; Dormán G; Szabó C
Int J Mol Med; 2007 Nov; 20(5):749-61. PubMed ID: 17912470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
